Results 121 to 130 of about 5,177,357 (230)
Gut wall physiology in multiple sclerosis (MS) and autoimmune neurologic diseases remains underexplored but may span gut barrier dysfunction, enteric glial targeting, mucosal immune dysregulation, and autoimmune targets within the enteric nervous system (ENS).
Federico Montini +4 more
wiley +1 more source
Introduction: Hepatobiliary overlap syndromes describe the coinciding presentation of more than one immune-mediated biliary and liver disease in a single patient and present complex challenges in diagnosis and treatment.
Hannah W. Fiske +7 more
doaj +1 more source
ABSTRACT Progressive familial intrahepatic cholestasis type 3 (PFIC3) is caused by biallelic mutations in the ABCB4 gene and typically presents in childhood. However, the full phenotypic spectrum—particularly adult‐onset and pruritus‐free forms—remains under‐recognized.
Rongxia Ma +3 more
wiley +1 more source
Medjool date seeds were dried, milled, and extracted (80°C, 180 min), followed by centrifugation (1000 rpm, 15 min) and BCA analysis to obtain the polysaccharide fraction (MDSP), which was characterized by TEM, FTIR, XPS, NMR, UV‐Vis, and TGA. In Balb/c mice with DSS‐induced colitis (2.25% DSS, Day 1.15), oral administration of MDSP‐H (300 mg/Kg ...
Sadeeq Ullah +10 more
wiley +1 more source
Imaging of Benign Biliary Tract Disease
This review article discusses the most common benign biliary disorders and the various radiological findings on multiple modalities. A broad spectrum of diseases including various congenital disorders, infective and parasitic etiologies, immunological ...
Samarjit Singh Ghuman +5 more
doaj +1 more source
Cholangiographic findings in deteriorating primary sclerosing cholangitis
The evolution of primary sclerosing cholangitis (PSC) is difficult to predict, and ERCP may be helpful in diagnosing its complications and treating them. Few descriptions of cholangiographic findings during the course of the disease have yet appeared. We
Bourgeois, Nadine +13 more
core +1 more source
Abstract Objectives The efficacy of cystic fibrosis transmembrane conductance regulator (CFTR)‐modulator therapies in preventing or ameliorating cystic fibrosis liver disease (CFLD) by correcting CFTR in cholangiocytes is not well‐documented. This study aimed to assess liver function during CFTR‐modulators.
Laura Giugliano +12 more
wiley +1 more source
Primary sclerosing cholangitis in a child with ulcerative colitis
The paper provides a clinical case of a patient with ulcerative colitis complicated by primary sclerosing cholangitis. Possible etiology, clinical symptoms, diagnostic criteria for laboratory and instrumental tests, as well as management tactics for ...
Alexandra V. Zenicheva +1 more
doaj +1 more source
Primary sclerosing cholangitis: refinement and validation of survival models.
The natural history of primary sclerosing cholangitis was studied in 426 patients from five medical centers. The median follow-up time was 3.0 years (range, 0.01-16.6 years); 100 patients had died by the time of last follow-up.
core +1 more source
A hepatic enigma: Pediatric presentation of primary biliary cholangitis
Abstract Primary biliary cholangitis (PBC) is a chronic autoimmune condition characterized by destruction of intrahepatic bile ducts, leading to fibrosis and cirrhosis of the liver. It is an extremely rare pediatric disease with very few pediatric cases reported to date. Here, we report the case of a 14‐year‐old female who presented with elevated liver
Sindhura Kasturi +3 more
wiley +1 more source

